Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

BioCryst Pharmaceuticals Inc (BCRX)

NASDAQ
Currency in USD
Disclaimer
4.47
-0.03(-0.56%)
Real-time Data

BCRX Comments

I'll buy at 10 dollars
i know you from you spamming gme
someone is loading big time for this to happen never seen a dip like this especially on a big day like today BCRX is all over the news and great news and this happen unbelievable 👏
BCX9930 phase 1 data presentation is on the 22nd of March
after such a great news this happened really come on should be in the 15s already
omg please hold guys I wish I could scream on everyone ears do not sell... hold your position this stock worth much more than this come on hold
finally we break 13 Jesus now lets go to 15 🙏
have a call option @15 really need to go there Exp on the 19th so lets see hopefully 😊
$BCRX What are the street expectations for next ER? This what I found: 2021 and 2022 total revenue estimates are $61 million and $121 million, respectively. and $600M US + $195M EU + $15M Japan = $805M annually at a super conservative half anticipated extremely conservative estimate. The company has noted in conference calls that they expect sales to be north of $500M at peak sales. We think that given our numbers listed above, which are widely conservative, that the company is being ultra conservative. We assume this is their approach to under promise and overdeliver which we can see is prudent and well thought out.
Its $9.48 now here, and why  BCRX Technical Analysis says STRONG SELL?
I never seen a stock like this so much good news-releases for what for this dropping and dropping we should of been at @13 minimum by now
They need to execute and maybe in one month when we have the ER we will see that
noooo 100% I will get screwed I have an option call expiring on the 19th and I bet It will fly after that day is crazy the way they manipulate stocks
HOLDING not expecting to see these prices again after all the Orladeyo data and Factor D progress are put into revised PT.
COTY$ is a buy people!!! Buy it for huge gains
one day it will get the respect it deserves..$30+.....
Why isn't it moving? News is very good. Cheers.
pre-mkt volume? Cheers.
dont worry boys. everything is down.
did you buy the dip?
will test 12.45 again
Hold. Will go up
people selling like crazy
Good news bruce, come with us to foro español
No bro foro español de investing
15% flota short
company subsidized by the government of usa and the NIAID. Revenue growth is expected 10 times higher than 2020 by Berotrastal
https://www.marketwatch.com/press-release/biocryst-announces-approval-of-orladeyotm-berotralstat-in-japan-for-the-prophylactic-treatment-of-hereditary-angioedema-2021-01-22?mod=mw_quote_news_seemore
is this a stock to invest in?
it's not too late before it runs up hard. Orladayo alone worth a 2B market cap at least.
today ìs biocryst conference.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.